Inozyme Pharma Inc (INZY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Operating Expenses | 22,808 | 18,074 | 16,394 | 18,369 | 19,533 |
| Operating Income | -22,808 | -18,074 | -16,394 | -18,369 | -19,533 |
| Interest Expense | 1,281 | 953 | 771 | 328 | 0 |
| Other Income | 2,545 | 2,389 | 1,582 | 1,293 | 989 |
| Pre-tax Income | -21,544 | -16,638 | -15,583 | -17,404 | -18,544 |
| Net Income Continuous | -21,544 | -16,638 | -15,583 | -17,404 | -18,544 |
| Net Income | $-21,544 | $-16,638 | $-15,583 | $-17,404 | $-18,544 |
| EPS Basic Total Ops | -0.33 | -0.29 | -0.35 | -0.40 | -0.31 |
| EPS Basic Continuous Ops | -0.33 | -0.29 | -0.35 | -0.40 | -0.30 |
| EPS Diluted Total Ops | -0.33 | -0.29 | -0.35 | -0.40 | -0.31 |
| EPS Diluted Continuous Ops | -0.33 | -0.29 | -0.35 | -0.40 | -0.30 |
| EPS Diluted Before Non-Recurring Items | -0.35 | -0.29 | -0.35 | N/A | N/A |
| EBITDA(a) | $-24,703 | $-19,350 | $-17,289 | $-18,908 | $-19,924 |